PT1368045E - Processo para obtenção de decoctos de cascas de vitis labrusca e vitis vinifera - Google Patents
Processo para obtenção de decoctos de cascas de vitis labrusca e vitis vinifera Download PDFInfo
- Publication number
- PT1368045E PT1368045E PT02702184T PT02702184T PT1368045E PT 1368045 E PT1368045 E PT 1368045E PT 02702184 T PT02702184 T PT 02702184T PT 02702184 T PT02702184 T PT 02702184T PT 1368045 E PT1368045 E PT 1368045E
- Authority
- PT
- Portugal
- Prior art keywords
- decoction
- vitis
- liquid phase
- lyophilisate
- ethyl acetate
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 54
- 235000004282 Vitis labrusca Nutrition 0.000 title claims abstract description 37
- 230000008569 process Effects 0.000 title claims abstract description 31
- 235000014787 Vitis vinifera Nutrition 0.000 title claims description 41
- 244000070384 Vitis labrusca Species 0.000 title claims description 38
- 240000006365 Vitis vinifera Species 0.000 title claims description 31
- 235000002532 grape seed extract Nutrition 0.000 title claims description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 67
- 206010020772 Hypertension Diseases 0.000 claims abstract description 25
- 238000011282 treatment Methods 0.000 claims abstract description 14
- 241000219095 Vitis Species 0.000 claims abstract description 13
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 230000002265 prevention Effects 0.000 claims abstract description 3
- 235000009392 Vitis Nutrition 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 239000000399 hydroalcoholic extract Substances 0.000 claims description 30
- 239000007791 liquid phase Substances 0.000 claims description 27
- 235000020679 tap water Nutrition 0.000 claims description 17
- 239000008399 tap water Substances 0.000 claims description 17
- 235000013399 edible fruits Nutrition 0.000 claims description 16
- 239000011148 porous material Substances 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 230000003285 pharmacodynamic effect Effects 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 230000000144 pharmacologic effect Effects 0.000 claims description 7
- 229920002261 Corn starch Polymers 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims description 6
- 239000008120 corn starch Substances 0.000 claims description 6
- 238000002803 maceration Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 1
- 230000002879 macerating effect Effects 0.000 claims 1
- 238000003809 water extraction Methods 0.000 claims 1
- 241000700159 Rattus Species 0.000 abstract description 24
- 230000004872 arterial blood pressure Effects 0.000 abstract description 21
- 239000000284 extract Substances 0.000 abstract description 20
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract description 14
- 208000037849 arterial hypertension Diseases 0.000 abstract description 12
- 239000002775 capsule Substances 0.000 abstract description 9
- 230000005764 inhibitory process Effects 0.000 abstract description 8
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 230000002269 spontaneous effect Effects 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 241001512058 Vitis labrusca x Vitis vinifera Species 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 241001465754 Metazoa Species 0.000 description 23
- KCWZGJVSDFYRIX-YFKPBYRVSA-N N(gamma)-nitro-L-arginine methyl ester Chemical compound COC(=O)[C@@H](N)CCCN=C(N)N[N+]([O-])=O KCWZGJVSDFYRIX-YFKPBYRVSA-N 0.000 description 16
- 230000003276 anti-hypertensive effect Effects 0.000 description 15
- 235000009754 Vitis X bourquina Nutrition 0.000 description 11
- 235000012333 Vitis X labruscana Nutrition 0.000 description 11
- 230000006978 adaptation Effects 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 9
- 235000020188 drinking water Nutrition 0.000 description 9
- 239000003651 drinking water Substances 0.000 description 9
- 241000283690 Bos taurus Species 0.000 description 7
- 241000700157 Rattus norvegicus Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- VPGRYOFKCNULNK-ACXQXYJUSA-N Deoxycorticosterone acetate Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)COC(=O)C)[C@@]1(C)CC2 VPGRYOFKCNULNK-ACXQXYJUSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000010903 husk Substances 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 241000885980 Vitacea Species 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- -1 for example Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- VZUGBLTVBZJZOE-KRWDZBQOSA-N n-[3-[(4s)-2-amino-1,4-dimethyl-6-oxo-5h-pyrimidin-4-yl]phenyl]-5-chloropyrimidine-2-carboxamide Chemical compound N1=C(N)N(C)C(=O)C[C@@]1(C)C1=CC=CC(NC(=O)C=2N=CC(Cl)=CN=2)=C1 VZUGBLTVBZJZOE-KRWDZBQOSA-N 0.000 description 2
- 238000011458 pharmacological treatment Methods 0.000 description 2
- 235000020095 red wine Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 125000002059 L-arginyl group Chemical class O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000013059 nephrectomy Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000036454 renin-angiotensin system Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Table Devices Or Equipment (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Extraction Or Liquid Replacement (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0106382-0A BRPI0106382B1 (pt) | 2001-03-13 | 2001-03-13 | Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1368045E true PT1368045E (pt) | 2006-12-29 |
Family
ID=36782358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02702184T PT1368045E (pt) | 2001-03-13 | 2002-03-12 | Processo para obtenção de decoctos de cascas de vitis labrusca e vitis vinifera |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040202737A1 (https=) |
| EP (1) | EP1368045B1 (https=) |
| JP (1) | JP2004525124A (https=) |
| AT (1) | ATE333283T1 (https=) |
| BR (1) | BRPI0106382B1 (https=) |
| CA (1) | CA2440333C (https=) |
| DE (1) | DE60213211T2 (https=) |
| ES (1) | ES2269650T3 (https=) |
| MX (1) | MXPA03008161A (https=) |
| PT (1) | PT1368045E (https=) |
| WO (1) | WO2002072118A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001122791A (ja) | 1999-10-20 | 2001-05-08 | Boehringer Ingelheim Internatl Gmbh | 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤 |
| EP1572221A1 (en) * | 2002-12-20 | 2005-09-14 | Council of Scientific and Industrial Research | Ayurvedic herbal soft drink |
| AU2003298180B2 (en) * | 2002-12-31 | 2010-01-21 | Boehringer Ingelheim International Gmbh | Film coated tablet comprising an extract of red vine leaves |
| JP2007523110A (ja) | 2004-02-19 | 2007-08-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 赤ブドウ葉の抽出物および抗炎症剤を含む、慢性静脈疾患を治療するための組成物 |
| BRPI0604281A (pt) * | 2006-07-18 | 2008-03-04 | Roberto Soares De Moura | processo para obtenção de decotos de frutos e caroços de euterpe oleracea (açaì) processo de obtenção de extratos hidro-alcoólicos a partir dos decotos; processo obtenção de liofilizado e/ou spray dryer do extrato hidro-alcoólico; composições farmacêuticas contendo os liofilizados e/ou spray dryer dos ditos extratos e uso terapêutico das composições como vasodilatador no tratamento das sìndromes isquêmicas, vaso-espásticas e da hipertenção arterial |
| JP5892436B2 (ja) * | 2011-08-26 | 2016-03-23 | ビーエイチエヌ株式会社 | 血圧降下剤 |
| KR102155113B1 (ko) * | 2019-10-30 | 2020-09-11 | 유한회사 한풍제약 | 고혈압 치료용 약학적 조성물 및 식품 조성물 |
| JP6953054B1 (ja) * | 2021-03-31 | 2021-10-27 | Ｄｅｌｔａ−Ｆｌｙ Ｐｈａｒｍａ株式会社 | 湿度に敏感な医薬用途物質を安定化する方法及び安定製剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2092743A1 (en) * | 1970-06-15 | 1972-01-28 | Aquitaine Invest Pharma | Complete extraction of total flavanol gomers from plats -peripheral - venous activity |
| IT1201151B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono |
| US5484594A (en) * | 1988-06-28 | 1996-01-16 | Tecnofarmaci S.P.A. | Process for preparing grapeseed extracts enriched in procyanidol oligomers |
| IT1255029B (it) * | 1992-05-11 | 1995-10-13 | Paolo Morazzoni | Formulazioni farmaceutiche orali contenenti antocianosidi |
| JP2695585B2 (ja) * | 1992-12-28 | 1997-12-24 | キヤノン株式会社 | 光起電力素子及びその製造方法、並びにそれを用いた発電装置 |
| US5536600A (en) * | 1994-09-23 | 1996-07-16 | Kaun; Thomas D. | Li-alloy electrode for Li-alloy/metal sulfide cells |
| FR2750606B1 (fr) * | 1996-07-03 | 1999-01-29 | Maurel Sante | Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant |
| US5912363A (en) * | 1997-08-29 | 1999-06-15 | Interhealth Nutraceuticals | Method for extraction of proanthocyanidins from plant material |
| FR2775686B1 (fr) * | 1998-03-09 | 2006-07-28 | Pascal Commenil | Exploitation industrielle et commerciale des lipides cuticulaires de la baie de raisin en pharmacologie et cosmetologie |
| IT1302365B1 (it) * | 1998-10-09 | 2000-09-05 | Sigma Tau Healthscience Spa | Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali |
| US20020192314A1 (en) * | 2001-03-06 | 2002-12-19 | Cho Suk H. | Dietary supplement compositions |
| US6918946B2 (en) * | 2001-07-02 | 2005-07-19 | Board Of Regents, The University Of Texas System | Applications of light-emitting nanoparticles |
| US20030134198A1 (en) * | 2001-09-28 | 2003-07-17 | Kabushiki Kaisha Toshiba | Negative electrode material, negative electrode, nonaqueous electrolyte battery and method of manufacturing a negative electrode material |
-
2001
- 2001-03-13 BR BRPI0106382-0A patent/BRPI0106382B1/pt not_active IP Right Cessation
-
2002
- 2002-03-12 EP EP02702184A patent/EP1368045B1/en not_active Expired - Lifetime
- 2002-03-12 WO PCT/BR2002/000038 patent/WO2002072118A1/en not_active Ceased
- 2002-03-12 US US10/469,990 patent/US20040202737A1/en not_active Abandoned
- 2002-03-12 PT PT02702184T patent/PT1368045E/pt unknown
- 2002-03-12 MX MXPA03008161A patent/MXPA03008161A/es active IP Right Grant
- 2002-03-12 JP JP2002571077A patent/JP2004525124A/ja active Pending
- 2002-03-12 DE DE60213211T patent/DE60213211T2/de not_active Expired - Lifetime
- 2002-03-12 CA CA002440333A patent/CA2440333C/en not_active Expired - Lifetime
- 2002-03-12 AT AT02702184T patent/ATE333283T1/de not_active IP Right Cessation
- 2002-03-12 ES ES02702184T patent/ES2269650T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002072118A1 (en) | 2002-09-19 |
| DE60213211D1 (de) | 2006-08-31 |
| CA2440333C (en) | 2009-02-24 |
| EP1368045B1 (en) | 2006-07-19 |
| MXPA03008161A (es) | 2004-11-12 |
| US20040202737A1 (en) | 2004-10-14 |
| JP2004525124A (ja) | 2004-08-19 |
| BRPI0106382B8 (https=) | 2021-05-25 |
| ATE333283T1 (de) | 2006-08-15 |
| BR0106382A (pt) | 2003-09-30 |
| DE60213211T2 (de) | 2007-07-19 |
| BRPI0106382B1 (pt) | 2017-07-11 |
| EP1368045A1 (en) | 2003-12-10 |
| CA2440333A1 (en) | 2002-09-19 |
| ES2269650T3 (es) | 2007-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100372561B1 (ko) | 천연 생약제 추출물을 포함하는 숙취해소용 조성물 및이를 유효성분으로 함유하는 건강보조식품 | |
| JP2002179586A (ja) | リパーゼ阻害剤 | |
| ES2398371T3 (es) | Composición que comprende los extractos de lindera obtusiloba para la prevención y el tratamiento de enfermedades cardiovasculares | |
| JP2004075638A (ja) | 血糖上昇抑制且つ血圧上昇抑制作用を有する機能性素材 | |
| ES2705169T3 (es) | Preparación y uso farmacéutico de composiciones de extracto de euterpe oleracea (açaí) | |
| WO2008004804A1 (en) | Trachelospermi caulis extract composition for the treatment and prevention of inflammatory diseases | |
| PT1368045E (pt) | Processo para obtenção de decoctos de cascas de vitis labrusca e vitis vinifera | |
| JAAFAR et al. | The Use of Pharmaceutical Preparation of Phytosome Lepidium Sativum Extract as Anti-diarrheal Induced by the Bacteria E. coli in Mice. | |
| US8455014B2 (en) | Composition comprising Trachelospermi caulis and Pyrola japonica extracts for the treatment and prevention of inflammatory diseases | |
| CN101360430B (zh) | 用于治疗过敏的功能性食物组合物、利用该组合物的天然茶及其制备方法 | |
| CN103169742A (zh) | 一种羊奶果的用途 | |
| JP2004352626A (ja) | 植物由来成分を含有する抗コレステロール剤 | |
| George et al. | A Review on Antidiabetic Properties of Momordica charantia | |
| KR20100094223A (ko) | 숙취해소용 음료수 조성물 | |
| KR102207952B1 (ko) | 실크 펩타이드를 포함하는 치매, 뇌졸증 및 인지 기능 개선용 조성물 | |
| US20070218151A1 (en) | Process for obtention of decoctions of Vitis labrusca and Vitis vinifera skins | |
| CN112843177B (zh) | 高金线兰提取物在制备治疗或缓解疼痛的药物或保健品中的应用 | |
| JP3411043B2 (ja) | 水虫治療剤 | |
| KR100761938B1 (ko) | 고지혈증 및/또는 고혈압에 기인한 발기부전 예방 또는치료용 약학 조성물 | |
| KR20210133603A (ko) | 굼벵이를 포함하는 치매 예방 또는 치료용 조성물 | |
| JP2011184360A (ja) | チュウゴクザサエキス、その製造方法及び用途 | |
| KR19990027764A (ko) | 동맥경화억제용 약제조성물 | |
| Ogbeche et al. | Blood Pressure Lowering Effect of the Seeds of Vitex doniana | |
| US20170290871A1 (en) | Method of treating hypertension | |
| BR112020019729A2 (pt) | água de vegetação e uso das mesmas |